Cargando…
Rs867228 in FPR1 accelerates the manifestation of luminal B breast cancer
Formyl peptide receptor-1 (FPR1) is a pathogen recognition receptor involved in the detection of bacteria, in the control of inflammation, as well as in cancer immunosurveillance. A single nucleotide polymorphism in FPR1, rs867228, provokes a loss-of-function phenotype. In a bioinformatic study perf...
Autores principales: | Carbonnier, Vincent, Le Naour, Julie, Bachelot, Thomas, Vacchelli, Erika, André, Fabrice, Delaloge, Suzette, Kroemer, Guido |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10038022/ https://www.ncbi.nlm.nih.gov/pubmed/36970071 http://dx.doi.org/10.1080/2162402X.2023.2189823 |
Ejemplares similares
-
A major genetic accelerator of cancer diagnosis: rs867228 in FPR1
por: Sztupinszki, Zsofia, et al.
Publicado: (2021) -
The ambiguous role of FPR1 in immunity and inflammation
por: Vacchelli, Erika, et al.
Publicado: (2020) -
An independent predictor of poor prognosis in locally advanced rectal cancer: rs867228 in formyl peptide receptor 1 (FPR1)
por: Chiang, Shu-Fen, et al.
Publicado: (2021) -
No impact of cancer and plague-relevant FPR1 polymorphisms on COVID-19
por: Petrazzuolo, Adriana, et al.
Publicado: (2020) -
A loss-of-function polymorphism in ATG16L1 compromises therapeutic outcome in head and neck carcinoma patients
por: Le Naour, Julie, et al.
Publicado: (2022)